1-6 of 6
Ping-Chiao Tsai
Close
Sort by
Journal Articles

Ublituximab (TGTX-1101), A Novel Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Activity in Rituximab-Sensitive and Rituximab–resistant B Non-Hodgkin Lymphoma (B-NHL) Pre-Clinical In vitro and in Vivo models.

John Miller, Matthew J. Barth, MD, Cory Mavis, BSc, MSc, Ping-Chiao Tsai, PhD, Pavel Klener, Jr., MD, PhD, Francisco Hernandez-Ilizaliturri, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2012) 120 (21): 2756.
https://doi.org/10.1182/blood.V120.21.2756.2756
Published: 2012
Journal Articles

Ofatumumab (OFA) Is a Novel Anti-CD20 Monoclonal Antibody (mAb) with Improved Anti-Tumor Activity in Vitro and in Vivo in Mantle Cell Lymphoma (MCL) Pre-Clinical Models.

Matthew J. Barth, MD, Gopichand Pendurti, MD, Ping-Chiao Tsai, PhD, Cory Mavis, BSc, MSc, Pavel Klener, Jr., Myron S. Czuczman, MD, Francisco Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2012) 120 (21): 2757.
https://doi.org/10.1182/blood.V120.21.2757.2757
Published: 2012
Journal Articles

Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenografts, and Primary Tumor Cells Derived From Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

Matthew Barth, MD, Francisco J. Hernandez-Ilizaliturri, MD, Cory Mavis, BSc, MSc, Ping-Chiao Tsai, John Gibbs, MD, George Deeb, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2010) 116 (21): 3917.
https://doi.org/10.1182/blood.V116.21.3917.3917
Published: 2010
Journal Articles

Rituximab Resistance Is Associated with Global Downregulation of CD20 and CD54 In B-Cell Lymphoma Cells: Implication of CD20 Signaling on CD54

Ping-Chiao Tsai, Peter Dvorak, Naveen Bangia, Scott Olejniczak, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2010) 116 (21): 5077.
https://doi.org/10.1182/blood.V116.21.5077.5077
Published: 2010
Journal Articles

The Acquirement of Rituximab Resistance Is Associated with a Global Downregulation of CD54 in B-Cell Lymphoma Cells: The Potential Role of Adhesion Molecules in Rituximab Anti-Tumor Activity

Ping-Chiao Tsai, Naveen Bangia, Scott Olejniczak, Francisco J. Hernandez-Ilizaliturri, Myron Czuczman
Journal: Blood
Blood (2008) 112 (11): 2607.
https://doi.org/10.1182/blood.V112.11.2607.2607
Published: 2008
Journal Articles

Modulation of CD20 Expression in Rituximab-Sensitive (RSCL) and Rituximab Resistant Cell Lines (RRCL) Using IL-4 and Bryostatin-1.

Ping-Chiao Tsai, Pre-Doc, Francisco J. Hernandez-Ilizaliturri, MD, Scott H. Olejniczak, Pre-Doc, Bangia Naveen, PhD, Myron S. Czuczman, MD
Journal: Blood
Blood (2007) 110 (11): 2619.
https://doi.org/10.1182/blood.V110.11.2619.2619
Published: 2007